1415 related articles for article (PubMed ID: 19232683)
41. Do heterozygous factor V Leiden and prothrombin G20210A mutations have different impact on the type and location of venous thromboembolism?
Chevalier Y; Mandrillon G; Bestion A; Lega JC; Piquet P; Ninet J; Dargaud Y
Int Angiol; 2014 Aug; 33(4):404-5. PubMed ID: 25056173
[No Abstract] [Full Text] [Related]
42. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
[TBL] [Abstract][Full Text] [Related]
43. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
[TBL] [Abstract][Full Text] [Related]
44. Factor V Leiden and prothrombin G20210A mutations in Thai patients awaiting kidney transplant.
Arnutti P; Nathalang O; Cowawintaweewat S; Prayoonwiwat W; Choovichian P
Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):869-71. PubMed ID: 12757241
[TBL] [Abstract][Full Text] [Related]
45. Simultaneous detection of FV Q506 and prothrombin 20210 A variation by allele-specific PCR.
Mitterer M; Lanthaler AJ; Mair W; Giacomuzzi K; Coser P
Haematologica; 1999 Mar; 84(3):204-7. PubMed ID: 10189382
[TBL] [Abstract][Full Text] [Related]
46. Factor V Leiden and prothrombin G20210A variant are risk factors for venous thromboembolism in the Argentinean population.
Adamczuk Y; Iglesias Varela ML; Forastiero R; Martinuzzo M; Cerrato G; Pombo G; Carreras LO
Thromb Haemost; 2000 Mar; 83(3):509-10. PubMed ID: 10744162
[No Abstract] [Full Text] [Related]
47. Factor V Leiden, prothrombin G20210A and MTHFR gene mutations in inflammatory bowel disease.
Törüner M; Erkan O; Soykan I; Bozdayi M; Cetinkaya H; Yurdaydin C; Uzunalimoğlu O; Ozden A
Turk J Gastroenterol; 2004 Dec; 15(4):250-2. PubMed ID: 16249980
[TBL] [Abstract][Full Text] [Related]
48. Concomitant heterozygous factor V Leiden mutation and homozygous prothrombin gene variant (G20210A) in patient with cerebral venous thrombosis.
Kurkowska-Jastrzebska I; Wicha W; Dowzenko A; Vertun-Baranowska B; Pytlewski A; Bogusławska R; Członkowska A
Med Sci Monit; 2003 May; 9(5):CS41-5. PubMed ID: 12761462
[TBL] [Abstract][Full Text] [Related]
49. Laboratory assessment of hypercoagulable state. A study in a group of patients with venous thromboembolism born in Chioggia.
Gessoni G; Valverde S; Canistro R; Trabuio E; Antico F; Manoni F
Minerva Med; 2007 Apr; 98(2):89-93. PubMed ID: 17519850
[TBL] [Abstract][Full Text] [Related]
50. Clinical characteristics of patients with factor V Leiden or prothrombin G20210A and a first episode of venous thromboembolism. Findings from the RIETE Registry.
Gadelha T; Roldán V; Lecumberri R; Trujillo-Santos J; del Campo R; Poggio R; Monreal M;
Thromb Res; 2010 Oct; 126(4):283-6. PubMed ID: 20627204
[TBL] [Abstract][Full Text] [Related]
51. The prevalence of factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece.
Ioannou HV; Mitsis M; Eleftheriou A; Matsagas M; Nousias V; Rigopoulos C; Vartholomatos G; Kappas AM
Int Angiol; 2000 Dec; 19(4):314-8. PubMed ID: 11305729
[TBL] [Abstract][Full Text] [Related]
52. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
Procare-GEHT Group
Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
[TBL] [Abstract][Full Text] [Related]
53. Venous thrombosis with both heterozygous factor V Leiden (R507Q) and factor II (G20210A) mutations.
Bhaijee F; Jordan B; Pepper DJ; Leacock R; Rock WA
Clin Lab Sci; 2012; 25(4):199-205. PubMed ID: 23330508
[TBL] [Abstract][Full Text] [Related]
54. Prothrombotic gene mutations and Crohn's disease; is there any association?
Over-Hamzaoglu H; Abaci N; Türe F; Alkim C; Tezel A; Avsar E; Tözün N
Hepatogastroenterology; 2005; 52(65):1467-9. PubMed ID: 16201098
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
[TBL] [Abstract][Full Text] [Related]
56. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model.
Eichinger S; Heinze G; Jandeck LM; Kyrle PA
Circulation; 2010 Apr; 121(14):1630-6. PubMed ID: 20351233
[TBL] [Abstract][Full Text] [Related]
57. [Prevalence of Factor V Leiden and the G20210A mutation of the prothrombin gene in a random group of patients with thrombotic episodes].
Alvarez A; Barroso A; Robledo M; Arranz E; Outeiriño J; Benítez J
Sangre (Barc); 1999 Feb; 44(1):7-12. PubMed ID: 10323090
[TBL] [Abstract][Full Text] [Related]
58. Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages.
Mahjoub T; Mtiraoui N; Tamim H; Hizem S; Finan RR; Nsiri B; Almawi WY
Am J Hematol; 2005 Sep; 80(1):12-9. PubMed ID: 16138341
[TBL] [Abstract][Full Text] [Related]
59. Factor V HR2 haplotype: a risk factor for venous thromboembolism in individuals with absence of Factor V Leiden.
Otrock ZK; Taher AT; Shamseddeen WA; Zaatari G; Bazarbachi A; Mahfouz RA
Ann Hematol; 2008 Dec; 87(12):1013-6. PubMed ID: 18654780
[TBL] [Abstract][Full Text] [Related]
60. [From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A].
Reitsma PH; van de Stolpe A
Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1843-5. PubMed ID: 11593787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
